Metabolomics for Prediction of Relapse in Graves' Disease: Observational Pilot Study
Background: There is a lack of biochemical markers for early prediction of relapse in patients with Graves' disease [GD], which may help to direct treatment decisions. We assessed the prognostic ability of a high-throughput proton NMR metabolomic profile to predict relapse in a well characteriz...
Main Authors: | Tristan Struja, Andreas Eckart, Alexander Kutz, Andreas Huber, Peter Neyer, Marius Kraenzlin, Beat Mueller, Christian Meier, Luca Bernasconi, Philipp Schuetz |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-10-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fendo.2018.00623/full |
Similar Items
-
Is Graves’ disease a primary immunodeficiency? New immunological perspectives on an endocrine disease
by: Tristan Struja, et al.
Published: (2017-09-01) -
Comparison of Five TSH-Receptor Antibody Assays in Graves’ disease: results from an observational pilot study
by: Tristan Struja, et al.
Published: (2019-04-01) -
Vasculite cerebral e doença de Basedow-Graves: relato de dois casos
by: Rocha Maria Sheila Guimarães, et al.
Published: (2001-01-01) -
Aumento del remodelado óseo como forma de presentación de enfermedad de Graves-Basedow
by: Gutiérrez Medina S, et al.
Published: (2013-03-01) -
Osteoma de la órbita en una anciana con enfermedad de Graves-Basedow Osteoma of the orbit in an elderly woman with Graves - Basedow disease
by: Alexis Castillo Belén, et al.
Published: (2010-01-01)